カテゴリ： GlobalData, アメリカ, 企業調査

Neurosigma Inc：企業の製品パイプライン分析2018

◆英語タイトル：Neurosigma Inc - Product Pipeline Analysis, 2018 Update
◆商品コード：DATA904C12200
◆発行会社（調査会社）：GlobalData
◆発行日：2018年12月
◆ページ数：43
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD1,500 ⇒換算￥222,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD2,250 ⇒換算￥333,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Neurosigma Inc (Neurosigma) is a life science company that develops and commercializes trigeminal nerve stimulation technologies for neurologic and psychiatric disorders. The company offers treatments for epilepsy, depression, attention deficit hyperactivity disorder, and post-traumatic stress disorders. It also conducts preclinical research and development, and phase clinical trials. The company trigeminal nerve stimulation has been investigated as a therapy for epilepsy, depression, attention deficity hyperactivity disorder, and post-traumatic stress disorder, Lennox-Gastaut syndrome and traumatic brain injuries, among others. NeuroSigma is headquartered in Los Angeles, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Neurosigma Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Neurosigma Inc Company Overview 5
Neurosigma Inc Company Snapshot 5
Neurosigma Inc Pipeline Products and Ongoing Clinical Trials Overview 5
Neurosigma Inc – Pipeline Analysis Overview 8
Neurosigma Inc – Key Facts 8
Neurosigma Inc – Major Products and Services 9
Neurosigma Inc Pipeline Products by Development Stage 10
Neurosigma Inc Ongoing Clinical Trials by Trial Status 12
Neurosigma Inc Pipeline Products Overview 14
Deep Brain Stimulation System – Cachexia 14
Deep Brain Stimulation System – Cachexia Product Overview 14
Deep Brain Stimulation System – Obesity 15
Deep Brain Stimulation System – Obesity Product Overview 15
Flow-Diverting TFN Stent 16
Flow-Diverting TFN Stent Product Overview 16
Micropatterned TFN Stent 17
Micropatterned TFN Stent Product Overview 17
Monarch eTNS System – ADHD 18
Monarch eTNS System – ADHD Product Overview 18
Monarch eTNS System – ADHD Clinical Trial 19
Monarch eTNS System – Depression 20
Monarch eTNS System – Depression Product Overview 20
Monarch eTNS System – Depression Clinical Trial 21
Monarch eTNS System – Epilepsy 22
Monarch eTNS System – Epilepsy Product Overview 22
Monarch eTNS System – Epilepsy Clinical Trial 23
Monarch eTNS System – Lennox-Gastaut Syndrome 24
Monarch eTNS System – Lennox-Gastaut Syndrome Product Overview 24
Monarch eTNS System – Post-Traumatic Stress Disorder 25
Monarch eTNS System – Post-Traumatic Stress Disorder Product Overview 25
Monarch eTNS System – Traumatic Brain Injury 26
Monarch eTNS System – Traumatic Brain Injury Product Overview 26
sTNS System – Epilepsy 27
sTNS System – Epilepsy Product Overview 27
Thin Film Nitinol Flow Diverting Stent 28
Thin Film Nitinol Flow Diverting Stent Product Overview 28
Neurosigma Inc – Key Competitors 29
Neurosigma Inc – Key Employees 30
Neurosigma Inc – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 32
Neurosigma Inc, Recent Developments 32
Oct 30, 2017: UCLA Team Reports Positive Topline Results from Double-Blind Trial of NeuroSigma’s Non-Invasive eTNS System for Treatment of Pediatric ADHD 32
Jan 28, 2016: Electric patch holds promise for treating PTSD 33
Dec 10, 2015: Preliminary Results Utilizing NeuroSigma’s Monarch eTNS System for the Treatment of Traumatic Brain Injury Presented at the North American Neuromodulation Society Annual Meeting 34
Nov 16, 2015: NeuroSigma’s Monarch eTNS System Receives CE Mark Approval for ADHD 34
May 04, 2015: NeuroSigma’s Thin Film Nitinol Flow Diverting Stent Results Presented at the American Society of Neuroradiology Meeting 35
Jan 06, 2015: FDA Grants NeuroSigma Humanitarian Use Device (HUD) Designation 35
Jan 05, 2015: UCLA Launches Phase II Pediatric Clinical Trial for the Treatment of ADHD with NeuroSigma’s eTNS System 36
Nov 19, 2014: NeuroSigma Congratulates Brazilian Medical Team for Their Top-Line Results in Phase II Clinical Trial of eTNS for Treatment of Depression 37
Nov 17, 2014: NeuroSigma Announces Top-Line Findings of UCLA Phase II Clinical Trial of eTNS for the Treatment of Depression 38
Nov 03, 2014: NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation 38
Appendix 40
Methodology 40
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Neurosigma Inc Pipeline Products and Ongoing Clinical Trials Overview 5
Neurosigma Inc Pipeline Products by Equipment Type 6
Neurosigma Inc Pipeline Products by Indication 7
Neurosigma Inc Ongoing Clinical Trials by Trial Status 7
Neurosigma Inc, Key Facts 8
Neurosigma Inc, Major Products and Services 9
Neurosigma Inc Number of Pipeline Products by Development Stage 10
Neurosigma Inc Pipeline Products Summary by Development Stage 11
Neurosigma Inc Ongoing Clinical Trials by Trial Status 12
Neurosigma Inc Ongoing Clinical Trials Summary 13
Deep Brain Stimulation System - Cachexia - Product Status 14
Deep Brain Stimulation System - Cachexia - Product Description 14
Deep Brain Stimulation System - Obesity - Product Status 15
Deep Brain Stimulation System - Obesity - Product Description 15
Flow-Diverting TFN Stent - Product Status 16
Flow-Diverting TFN Stent - Product Description 16
Micropatterned TFN Stent - Product Status 17
Micropatterned TFN Stent - Product Description 17
Monarch eTNS System - ADHD - Product Status 18
Monarch eTNS System - ADHD - Product Description 18
Monarch eTNS System - ADHD - Developmental Pilot Study of External Trigeminal Nerve Stimulation for ADHD 19
Monarch eTNS System - Depression - Product Status 20
Monarch eTNS System - Depression - Product Description 20
Monarch eTNS System - Depression - Effect of TNS for Major Depressive Disorder in the Elderly: A Phase II Randomized Controlled Trial 21
Monarch eTNS System - Depression - External Trigeminal Nerve Stimulation (eTNS) for the Treatment of Depression 21
Monarch eTNS System - Depression - Transcutaneous Vagus Nerve Stimulation for Treating Major Depressive Disorder: A Phase II, Randomized, Double-blind Clinical Trial 21
Monarch eTNS System - Epilepsy - Product Status 22
Monarch eTNS System - Epilepsy - Product Description 22
Monarch eTNS System - Epilepsy - Evaluation of the Monarch eTNS Therapy for Neurological and Neuropsychiatric Disorders in Pediatrics 23
Monarch eTNS System - Epilepsy - External Trigeminal Nerve Stimulation for Epilepsy 23
Monarch eTNS System - Lennox-Gastaut Syndrome - Product Status 24
Monarch eTNS System - Lennox-Gastaut Syndrome - Product Description 24
Monarch eTNS System - Post-Traumatic Stress Disorder - Product Status 25
Monarch eTNS System - Post-Traumatic Stress Disorder - Product Description 25
Monarch eTNS System - Traumatic Brain Injury - Product Status 26
Monarch eTNS System - Traumatic Brain Injury - Product Description 26
sTNS System - Epilepsy - Product Status 27
sTNS System - Epilepsy - Product Description 27
Thin Film Nitinol Flow Diverting Stent - Product Status 28
Thin Film Nitinol Flow Diverting Stent - Product Description 28
Neurosigma Inc, Key Employees 30
Neurosigma Inc, Subsidiaries 31
Glossary 42

List of Figures
Neurosigma Inc Pipeline Products by Equipment Type 6
Neurosigma Inc Pipeline Products by Development Stage 10
Neurosigma Inc Ongoing Clinical Trials by Trial Status 12

★海外企業調査レポート[Neurosigma Inc：企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Argan Inc (AGX)：企業の財務・戦略的SWOT分析
    Argan Inc (AGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Rizal Commercial Banking Corp (RCB)：電力：M&Aディール及び事業提携情報
    Summary Rizal Commercial Banking Corp (RCBC) is a commercial and financial banking service provider that offers corporate, commercial, and consumer banking, cash management, treasury, and remittance products and services. The company’s electronic banking services include mobile banking, internet ban …
  • Janssen Pharmaceuticals Inc：医療機器：M&Aディール及び事業提携情報
    Summary Janssen Pharmaceuticals Inc (Janssen), a subsidiary of Johnson & Johnson is a pharmaceutical company that develops drugs. The company offers medicines for an array of health conditions in therapeutic areas of attention deficit hyperactivity disorder, general medicine, mental health, neurolog …
  • Jubilee Life Insurance Company Limited：企業の戦略・SWOT・財務情報
    Jubilee Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary Jubilee Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Fresenius Medical Care AG & Co KGaA (FME)：企業の財務・戦略的SWOT分析
    Fresenius Medical Care AG & Co KGaA (FME) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Trident Systems Incorporated：企業の戦略・SWOT・財務情報
    Trident Systems Incorporated - Strategy, SWOT and Corporate Finance Report Summary Trident Systems Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Naval Group：戦略・SWOT・企業財務分析
    Naval Group - Strategy, SWOT and Corporate Finance Report Summary Naval Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Coca-Cola HBC AG：企業の戦略・SWOT・財務情報
    Coca-Cola HBC AG - Strategy, SWOT and Corporate Finance Report Summary Coca-Cola HBC AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Securitas AB (SECU B)：企業の財務・戦略的SWOT分析
    Securitas AB (SECU B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Tobira Therapeutics Inc (TBRA)-医療機器分野：企業M&A・提携分析
    Summary Tobira Therapeutics Inc (Tobira), formerly Regado Biosciences, Inc, which develops and commercializes therapies for the treatment of to treat non-alcoholic steatohepatitis (NASH) and other liver diseases, inflammation, fibrosis and HIV. Its pipeline products include Cenicriviroc (CVC) and Ev …
  • Guy’s and St Thomas’ NHS Foundation Trust：企業の戦略的SWOT分析
    Guy's and St Thomas' NHS Foundation Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Nippon Paint Holdings Co Ltd (4612)：企業の財務・戦略的SWOT分析
    Nippon Paint Holdings Co Ltd (4612) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Romelectro S.A.：企業の戦略的SWOT分析
    Romelectro S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Ergon Inc：企業の戦略的SWOT分析
    Ergon Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • The Gunma Bank Ltd
    The Gunma Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Gunma Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • ContraFect Corp (CFRX)：企業の財務・戦略的SWOT分析
    Summary ContraFect Corp (ContraFect) is a clinical stage biotechnology company that discovers and develops therapeutic protein and antibody products. The company develops products using lysin and monoclonal antibody platforms for the treatment of life threatening, drug-resistant infectious diseases. …
  • Maruha Nichiro Corporation：戦略・SWOT・企業財務分析
    Maruha Nichiro Corporation - Strategy, SWOT and Corporate Finance Report Summary Maruha Nichiro Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Sahara Energy Ltd (SAH)：石油・ガス：M&Aディール及び事業提携情報
    Summary Sahara Energy Ltd (Sahara Energy) is an oil and gas exploration and development company that acquires, exploits, explores, and develops oil and natural gas reserves in Western Canada. The company evaluates oil and gas exploration properties in Canada. It plans on growing through the drill bi …
  • KT Corporation：企業の戦略・SWOT・財務情報
    KT Corporation - Strategy, SWOT and Corporate Finance Report Summary KT Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Manhattan Beer Distributors：企業の戦略・SWOT・財務情報
    Manhattan Beer Distributors - Strategy, SWOT and Corporate Finance Report Summary Manhattan Beer Distributors - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆